SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-034398
Filing Date
2017-06-27
Accepted
2017-06-27 16:34:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 TO SCHEDULE 13D v469789_sc13da.htm SC 13D/A 51292
  Complete submission text file 0001144204-17-034398.txt   53116
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1010 STONY HILL ROAD SUITE 200 YARDLEY PA 19067
Business Address 1010 STONY HILL ROAD SUITE 200 YARDLEY PA 19067 215-702-8550
Alliqua BioMedical, Inc. (Subject) CIK: 0001054274 (see all company filings)

IRS No.: 582349413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85477 | Film No.: 17932747
SIC: 3841 Surgical & Medical Instruments & Apparatus